The orthopedic soft tissue repair devices market share is forecast to reach USD 5,633.11 million, after growing at a CAGR of 11.05% during 2023-2027. The rising geriatric population across the globe is analyzed to boost the orthopedic soft tissue repair devices market growth. Moreover, the growing use of orthopedic devices in emerging economies is the major trend enhancing the overall market demand for orthopedic soft tissue repair devices during the forecast period.
Get a snapshot of the orthopedic soft tissue repair devices market analysis: Unlock the Sample Report The report includes historic market data from 2017 to 2021. In 2017, the market was valued at USD 5186.08 million.
Browse Technavio's 166-page report and in-depth TOC on "Orthopedic soft tissue repair devices by product type (fixation devices, tissue scaffold, and cell therapy-based), end-user (hospitals and clinics, ambulatory surgical centers, and physician's offices), and geography (North America, Europe, Asia, and Rest of World).
View detailed Table of Contents Here: https://www.technavio.com/report/orthopedic-soft-tissue-repair-devices-market-analysis
Product type:
Fixation devices: The market share growth by the fixation devices segment will be significant during the forecast period. The growing need for fixation devices in orthopedic soft tissue repair will drive the growth of the segment in the global market during the forecast period.
Tissue scaffold
Cell therapy-based
Geography:
North America: 45% of market growth will develop from North America during the forecast period. Rising healthcare spending and investments in the sector's infrastructure are also major contributors to the region's expansion, as they can lower the cost of expensive orthopedic soft tissue repair surgeries.
Europe
Asia
Rest of World (ROW)
End-user:
Hospitals and clinics
Ambulatory surgical centers
Physician's offices
The orthopedic soft tissue repair devices market size will witness a YOY Growth Rate of 10.58% in 2023.
The lack of availability of skilled personnel for the use of orthopedic soft tissue repair devices will be a major challenge for the orthopedic soft tissue repair devices market during the forecast period.
Major key orthopedic soft tissue repair devices market players include: Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as the North America, Europe, Asia, and Rest of World (ROW).
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the orthopedic soft tissue repair devices market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the orthopedic soft tissue repair devices market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the orthopedic soft tissue repair devices market.
Orthopedic soft tissue repair devices industry growth across North America, Europe, Asia, and Rest of World (ROW).
